stockrowGrifols, S.A. (GRFS) vs Scilex Holding Company (SCLX)
- Grifols, S.A. GRFS 8.43 −0.35%
- Scilex Holding Company SCLX 1.70 0.00%
Grifols, S.A. and Scilex Holding Company are both Drug Manufacturers General companies. Grifols, S.A. is the larger, with a market value of $2.2B against $12.0M — 182.3× the size. Scilex Holding Company has negative trailing earnings, so its P/E is not meaningful; Grifols, S.A. trades at 18.2×. Grifols, S.A. grew revenue faster over the last twelve months: 10.9% against −28.6%. Grifols, S.A. has the higher net margin (6.02% vs −1,418.5%) and the higher return on invested capital (4.76% vs 0.00%). Across the 18 metrics below, Grifols, S.A. leads on 12 and Scilex Holding Company on 6.
Valuation
Profitability
| Metric | GRFS | SCLX | Drug Manufacturers General median |
|---|---|---|---|
| Gross margin | 37.55% | 55.50% | 73.01% |
| Operating margin | 16.69% | (1,136.40%) | 18.34% |
| Net margin | 6.02% | (1,418.45%) | 7.31% |
| Free cash flow margin | 8.51% | (56.37%) | 18.56% |
| Return on equity | 5.80% | 160.27% | 5.80% |
| Return on assets | 2.28% | (265.83%) | 2.28% |
| Return on invested capital | 4.76% | 0.00% | 6.26% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack